| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$73 |
Change of Director's Interest Notice - Mpofu
|
26 Nov 2024 8:44AM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$73 |
Change of Director's Interest Notice - Lennox
|
26 Nov 2024 8:43AM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
2024 AGM Presentation 261124
|
26 Nov 2024 8:43AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
| EML Payments Limited (EML) ORDINARY FULLY PAID |
Financials |
$417 |
EML 2.0 Strategy Plan Investor Presentation & Trading Update
|
26 Nov 2024 8:43AM |
$0.685 |
$1.090 |
risen by
59.12%
|
|
EML - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading for Q1 FY25 is in line with management expectations.
- GDV increased by 7% to A$5,857 million.
- Revenue increased by 12% to A$48.8 million.
- Underlying EBITDA guidance for FY25 reaffirmed at A$54-60 million.
- EML Payments operates globally in Australia, the UK, Europe, and the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$73 |
Change of Director's Interest Notice - Gomwe
|
26 Nov 2024 8:42AM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$619 |
Update - Notification of buy-back - FPR
|
26 Nov 2024 8:40AM |
$3.230 |
$2.790 |
fallen by
13.62%
|
|
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,187 |
Update - Notification of buy-back - AOV
|
26 Nov 2024 8:40AM |
$10.200 |
$8.740 |
fallen by
14.31%
|
|
| Aroa Biosurgery Limited (ARX) ORDINARY FULLY PAID |
Health Care |
$221 |
Aroa Biosurgery Half Yearly Results H1 FY25
|
26 Nov 2024 8:39AM |
$0.650 |
$0.640 |
fallen by
1.54%
|
|
ARX - Price-sensitive ASX Announcement
Full Release
Key Points
- Product sales grew by 25% to NZ$39.1 million.
- Sales of Myriad products increased by 45% to NZ$14.8 million.
- Total reported revenue grew by 23% to NZ$39.2 million.
- Normalised EBITDA loss decreased to NZ$1.5 million from NZ$2.7 million.
- Company remains debt-free with a cash balance of NZ$21.6 million.
- Full-year FY25 guidance maintained at NZ$80-87 million total revenue.
- AROA's Myriad active accounts grew to 265, up from 218.
- Eight peer-reviewed studies published during the reporting period.
- Progressing commercialisation of the Enivo platform.
- Successful completion of the annual DEKRA audit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aroa Biosurgery Limited (ARX) ORDINARY FULLY PAID |
Health Care |
$221 |
Appendix 4D and Half Year Report
|
26 Nov 2024 8:38AM |
$0.650 |
$0.640 |
fallen by
1.54%
|
|
ARX - Price-sensitive ASX Announcement
Full Release
Key Points
- Product sales grew by 25% compared to H1 FY24.
- Aroa expects positive cash flow in H2 FY25.
- Clinical evidence supporting ECM products is being expanded.
- Loss before tax decreased by 53% compared to the previous period.
- Net cash outflow from operating activities reduced by 33%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$108 |
Australia Patent Granted for RECCE Anti-Infectives
|
26 Nov 2024 8:37AM |
$0.470 |
$0.375 |
fallen by
20.21%
|
|
RCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Patent Family 3 granted by Australian Patent Office.
- RECCE® 327 and RECCE® 529 patents now protected until 2037.
- Covers manufacturing processes and treatment uses for infections.
- Protection extends across all major pharmaceutical markets.
- CEO highlights potential in addressing viral threats.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EML Payments Limited (EML) ORDINARY FULLY PAID |
Financials |
$417 |
Chairman and CEO Address - 2024 AGM
|
26 Nov 2024 8:36AM |
$0.685 |
$1.090 |
risen by
59.12%
|
|
EML - Price-sensitive ASX Announcement
Full Release
Key Points
- The 2024 AGM showcased EML's progress and future growth strategies.
- EML Payments Limited aims for double-digit transaction revenue growth by FY27.
- Significant improvements in financial performance were reported for FY24.
- The company has addressed historical challenges and strengthened its foundation.
- Strategic initiatives include nurturing customer relationships and entering new markets.
- Investment in technology is prioritized for operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$44 |
INOVIQ receives $1m RDTI refund
|
26 Nov 2024 8:36AM |
$0.440 |
$0.395 |
fallen by
10.23%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ receives $1.018m R&D Tax Incentive refund.
- Refund relates to FY24 R&D activities.
- R&D Tax Incentive provides 43.5% refundable tax offset.
- INOVIQ incurred $2.7m on eligible R&D activities.
- Company developing next-generation diagnostics and therapeutics for cancer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$137 |
NMR accelerates plans to re-start production at QLD project
|
26 Nov 2024 8:34AM |
$0.037 |
$0.140 |
risen by
278.38%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- NMR is accelerating plans for potential gold production from recently acquired BlackJack and Far Fanning gold deposits in Queensland.
- The BlackJack processing plant can be refurbished allowing for production before end of CY2025.
- Diamond drilling program at Far Fanning set to commence soon to upgrade the Inferred Mineral Resource Estimate.
- Sampling of stockpiles and waste ore at Far Fanning continues, with many samples returning grades above 0.5g/t Au.
- NMR plans to conduct metallurgical testing on stockpiled material for onsite processing.
- Engagement of specialized contractors has begun for the plant's inspection and refurbishment.
- Remediation works of administration buildings and site security measures have been initiated.
- Managing Director Blake Cannavo has extensive experience in mining and construction sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kogan.com Ltd (KGN) ORDINARY FULLY PAID |
Consumer Discretionary |
$381 |
Update - Notification of buy-back - KGN
|
26 Nov 2024 8:31AM |
$4.970 |
$3.840 |
fallen by
22.74%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$131 |
Update - Notification of buy-back - VVA
|
26 Nov 2024 8:31AM |
$1.360 |
$1.290 |
fallen by
5.15%
|
|
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$193 |
Endeavor Exploration update
|
26 Nov 2024 8:31AM |
$0.700 |
$0.720 |
risen by
2.86%
|
|
POL - Price-sensitive ASX Announcement
Full Release
Key Points
- Carpark Prospect EM Conductor Plate drilling to commence during January 2025.
- New high-ranking prospects identified within Exploration & Mining Licence areas.
- Regional exploration to kick off in Q1 CY2025 starting with 18km of IP survey lines.
- Polymetals has identified 9 near mine exploration targets.
- Carpark is a potential southern extension to the Endeavor orebody.
- Twelve RC/core holes over Carpark have intercepted broad zones of mineralisation.
- Next phase of drilling at Carpark will test for a massive sulphide body.
- The company plans to ramp up exploration activities over its entire Endeavor Project tenure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$125 |
Notification regarding unquoted securities - ALA
|
26 Nov 2024 8:29AM |
$0.190 |
$0.105 |
fallen by
44.74%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$1,937 |
Net Tangible Asset Backing
|
26 Nov 2024 8:28AM |
$3.040 |
$3.080 |
risen by
1.32%
|
|
| NobleOak Life Limited (NOL) ORDINARY FULLY PAID |
Financials |
$128 |
2024 AGM - Chair and CEO Addresses
|
26 Nov 2024 8:28AM |
$1.675 |
$1.380 |
fallen by
17.61%
|
|
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$176 |
ARR Reports Highest Grades to date at Cowboy State Mine
|
26 Nov 2024 8:27AM |
$0.280 |
$0.315 |
risen by
12.50%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- Final assay results confirm highest-grade TREO intersections at Cowboy State Mine.
- Significant high-grade intervals include HC24-RM046: 148.0 m @ 4,451 ppm TREO.
- Drilling reveals multiple high-grade intersections exceeding 5,000 ppm TREO.
- Results strengthen Halleck Creek's position as a promising rare earth development.
- Company is advancing toward an updated resource estimate and Pre-Feasibility Study for Halleck Creek.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argo Investments Limited (ARG) ORDINARY FULLY PAID |
Financials |
$7,077 |
Update - Notification of buy-back - ARG
|
26 Nov 2024 8:26AM |
$9.030 |
$9.300 |
risen by
2.99%
|
|
| OFX Group Limited (OFX) ORDINARY FULLY PAID |
Financials |
$191 |
Update - Notification of buy-back - OFX
|
26 Nov 2024 8:26AM |
$1.330 |
$0.815 |
fallen by
38.72%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$116 |
Update - Notification of buy-back - TOP
|
26 Nov 2024 8:26AM |
$0.630 |
$0.665 |
risen by
5.56%
|
|
| 29Metals Limited (29M) ORDINARY FULLY PAID |
Materials |
$391 |
High-grade Copper Intercepts Extend Europa
|
26 Nov 2024 8:26AM |
$0.385 |
$0.285 |
fallen by
25.97%
|
|
| Pioneer Lithium Limited (PLN) ORDINARY FULLY PAID |
Materials |
$5 |
Initial Director's Interest Notice - ZK
|
26 Nov 2024 8:26AM |
$0.160 |
$0.120 |
fallen by
25%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
